Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


May 24, 2015 12:13 PM ET

Life Sciences Tools and Services

Company Overview of Second Genome, Inc.

Company Overview

Second Genome, Inc., a life sciences company, develops microbiome-modulating precision therapies. Its microbiome signature discovery services include solutions for microbiome analysis, such as biological specimen storage and sample preparation; sequencing (NGS) and array-based metagenomic assays; and bioinformatics pipelines. Second Genome, Inc. was formerly known as PhyloTech, Inc. and changed its name to Second Genome, Inc. in January 2011. The company was founded in 2009 and is based in San Bruno, California.

1150 Bayhill Drive

Suite 215

San Bruno, CA 94066

United States

Founded in 2009

Phone:

650-440-4606

Key Executives for Second Genome, Inc.

Chief Executive Officer and President
Chairman of The Board and Co-Founder
Age: 57
Co-Founder and Chairperson of Scientific Advisory Board
Co-Founder and Head of Bioinformatics
Senior Vice President of Corporate Development
Age: 50
Compensation as of Fiscal Year 2014.

Second Genome, Inc. Key Developments

Second Genome, Inc. and Evotec AG to Collaborate in Microbiome Discovery and Development

Evotec AG and Second Genome, Inc. announced a collaboration in small molecule-based discovery and development activities for the treatment of microbiome-mediated diseases. The collaboration comprises the identification and optimisation of novel compounds as well as licence agreements for already existing assets developed by Evotec. Second Genome's unique approach to identify and modulate microbiome-mediated pathways will be further enhanced by the use and the results of Evotec's integrated drug discovery platform. As part of the collaboration, Second Genome and Evotec will work together to screen microbiome-mediated targets of interest identified by the Second Genome microbiome discovery platform with Evotec's technology platform, chemical libraries and other pre-clinical capabilities. The agreement between Evotec and Second Genome triggers an undisclosed upfront payment. Evotec is also eligible for pre-clinical, clinical and regulatory milestones as well as royalty payments related to commercialisation.

Second Genome, Inc. Presents at BioCentury 22nd Annual Future Leaders in the Biotech Industry Conference, Mar-20-2015 02:10 PM

Second Genome, Inc. Presents at BioCentury 22nd Annual Future Leaders in the Biotech Industry Conference, Mar-20-2015 02:10 PM. Venue: Millennium Broadway Hotel & Conference Center, New York, New York, United States.

Second Genome, Inc. Presents at 17th Annual BIO CEO & Investor Conference, Feb-10-2015 08:00 AM

Second Genome, Inc. Presents at 17th Annual BIO CEO & Investor Conference, Feb-10-2015 08:00 AM. Venue: The Waldorf Astoria, New York, New York, United States. Speakers: Karim Dabbagh, Chief Scientific Officer.

Similar Private Companies By Industry

Company Name Region
Crimson Life Sciences United States
Courtagen Life Sciences, Inc United States
Almac Clinical Services Inc. United States
BioLife Plasma Services L.P. United States
Worldwide Clinical Trials Drug Development Solutions, Inc. United States

Recent Private Companies Transactions

Type
Date
Target
Private Placement
October 7, 2014
--
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Second Genome, Inc., please visit www.secondgenome.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.